EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution

John D Sheppard, David G Evans, Eugene E Protzko

The American Journal of Managed Care · 2023

DOI: 10.37765/ajmc.2023.89464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The American Journal of Managed Care, 2023. Verfasst von John D Sheppard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Eye Consultants, 241 Corporate Boulevard. Norfolk, VA 23502. mmarino@cvphealth.com. Hauptthemen laut MEDLINE: Dry Eye Syndromes. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesAnimalsHumansRabbitsOphthalmic SolutionsInflammationLipidsFluorocarbons

Substanzen

Ophthalmic SolutionsLipidsperfluorohexyl-octanFluorocarbons

Autor:innen und Institutionen

  • Virginia Eye Consultants, 241 Corporate Boulevard. Norfolk, VA 23502. mmarino@cvphealth.com.

Zitieren

APA

Sheppard, J. D., Evans, D. G., & Protzko, E. E. (2023). A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2023.89464

Vancouver

Sheppard JD, Evans DG, Protzko EE. A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution. The American Journal of Managed Care. 2023. doi:10.37765/ajmc.2023.89464

BibTeX
@article{Sheppard2023,
  author = {Sheppard, John D and Evans, David G and Protzko, Eugene E},
  title = {A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution},
  journal = {The American Journal of Managed Care},
  year = {2023},
  doi = {10.37765/ajmc.2023.89464}
}
Kostenlos starten →